Ditto Bio
Ditto Bio42
About
What does Ditto Bio do?
Ditto Bio uses an AI platform to analyze genomes of primate-infecting viruses, parasitic worms, and ticks to surface proteins that modulate the human immune system. These naturally evolved immunomodulatory proteins become the basis for next-generation autoimmune therapeutics. The company has analyzed over 1 million parasite proteins and is building a proprietary tissue biobank to predict immunogenicity — one of the biggest failure points for protein therapeutics.
What is Ditto Bio's revenue?
StartupHub estimates Ditto Bio's annual revenue at $1.1M (range $642K to $2.0M, 64% confidence), based on comparable companies in the sector.
When was Ditto Bio founded?
Ditto Bio was founded in 2025.
What industry does Ditto Bio operate in?
Ditto Bio operates in Biotech, Drug Discovery, Autoimmune, Computational Biology, Healthcare, Genomics.
How many employees does Ditto Bio have?
Ditto Bio has approximately 5 people on record.
Where is Ditto Bio headquartered?
Ditto Bio is headquartered in San Francisco, USA.
No comments yet. Be the first to share your take.